IBD-associated C1orf106 mutations increases Arf6 activation (GTP bound Arf6, Arf6-GTP), which in turn impairs the integrity of intestinal epithelial cells by promoting the endocytosis of E-cadherin, a protein that is important for maintaining the epithelial barrier (30). Here, INAVA is linked to inflammatory bowel disease.